Prognostic Significance of Inflammatory Markers in Patients with Oral Cavity Cancers
Yıl: 2020 Cilt: 10 Sayı: 1 Sayfa Aralığı: 271 - 277 Metin Dili: İngilizce DOI: 10.32448/entupdates.696940 İndeks Tarihi: 24-12-2020
Prognostic Significance of Inflammatory Markers in Patients with Oral Cavity Cancers
Öz: Introduction: In the present study, we aimed to evaluatethe relationship between neutrophil/lymphocyte ratio(NLR), platelet/lymphocyte ratio (PLR) and systemic immune inflammation index (SII) values and overall survival(OS) and disease-free survival (DFS) in patientsundergoing radiotherapy (RT) with a diagnosis of oralcavity cancer (OCC).Methods: 58 patients were included who were treatedwith a diagnosis of OCC who applied to Cumhuriyet University Faculty of Medicine Radiation Oncology Clinic between January 2009 and December 2018. Kaplan-Meieranalysis was used to determine OS and DFS. MultivariateCox regression analysis was also performed to detect independent prognostic factors.Results: All patients had a squamous cell carcinoma (SCC)of the oral cavity composed of 50 tongue SCC and 8 buccal SCC. Cut-off values in ROC analysis: 954 [Area=0.665(0.511-0.800), p=0.06] for SII, 174 [Area=0.659 (0.608-0.795), p<.001] for PLR and 3.2 [Area=0.699 (0.556-0.841),p=0.016] for NLR. Prognostic factors affecting OS wereSII, PLR, NLR and age. SII, NLR, PLR and grade were statistically significant prognostic factors for DFS. However, SIIwas an independent prognostic factor.Conclusion: In this study, high SII value was found to bean indicator of shorter OS and DFS in patients with OCC.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Olgu Sunumu Erişim Türü: Erişime Açık
- 1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin 2015;65:87-108.
- 2. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69:7-34.
- 3. T.C. Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü. Türkiye Kanser İstatistikleri 2015. Ankara: 2018. p. 7-14.
- 4. Moore MM, Chua W, Charles KA, Clarke SJ. Inflammation and cancer: causes and consequences. Clin Pharmacol Ther 2010;87:504-8.
- 5. Stotz M, Gerger A, Eisner F, et al. Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer. Br J Cancer 2013;109:416-21.
- 6. Halazun KJ, Hardy MA, Rana AA, et al. Negative impact of neutrophil-lymphocyte ratio on outcome after liver transplantation for hepatocellular carcinoma. Ann Surg 2009;250:141-51.
- 7. Dan J, Zhang Y, Peng Z, et al. Postoperative neutrophil-to-lymphocyte ratio change predicts survival of patients with small hepatocellular carcinoma undergoing radiofrequency ablation. PLoS One 2013;8:e58184.
- 8. Gomez D, Farid S, Malik HZ, et al. Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma. World J Surg 2008;32:1757-62.
- 9. Halazun KJ, Aldoori A, Malik HZ, et al. Elevated preoperative neutrophil to lymphocyte ratio predicts survival following hepatic resection for colorectal liver metastases. Eur J Surg Oncol 2008;34:55-60.
- 10. Kishi Y, Kopetz S, Chun YS, Palavecino M, Abdalla EK, Vauthey JN. Blood neutrophil-to-lymphocyte ratio predicts survival in patients with colorectal liver metastases treated with systemic chemotherapy. Ann Surg Oncol 2009;16:614-22.
- 11. Zhang Y, Peng Z, Chen M, et al. Elevated neutrophil to lymphocyte ratio might predict poor prognosis for colorectal liver metastasis after percutaneous radiofrequency ablation. Int J Hyperthermia 2012;28:132-40.
- 12. Gasic GJ, Gasic TB, Stewart CC. Antimetastatic effects associated with platelet reduction. Proc Natl Acad Sci U S A 1968;61:46-52.
- 13. Gasic GJ, Gasic TB, Galanti N, Johnson T, Murphy S. Platelet-tumor-cell interactions in mice. The role of platelets in the spread of malignant disease. Int J Cancer 1973;11:704-18.
- 14. Jin DK, Shido K, Kopp HG, et al. Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes. Nat Med 2006;12:557-67.
- 15. Hu B, Yang XR, Xu Y, et al. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clin Cancer Res 2014;20:6212-22.
- 16. Hong X, Cui B, Wang M, Yang Z, Wang L, Xu Q. Systemic Immune-inflammation Index, Based on Platelet Counts and Neutrophil-Lymphocyte Ratio, Is Useful for Predicting Prognosis in Small Cell Lung Cancer. Tohoku J Exp Med 2015;236:297-304.
- 17. Lolli C, Basso U, Derosa L, et al. Systemic immune-inflammation index predicts the clinical outcome in patients with metastatic renal cell cancer treated with sunitinib. Oncotarget 2016;7:54564-71.
- 18. Lolli C, Caffo O, Scarpi E, et al. Systemic Immune-Inflammation Index Predicts the Clinical Outcome in Patients with mCRPC Treated with Abiraterone. Front Pharmacol 2016;7:376.
- 19. Feng JF, Chen S, Yang X. Systemic immune-inflammation index (SII) is a useful prognostic indicator for patients with squamous cell carcinoma of the esophagus. Medicine (Baltimore) 2017;96:5886.
- 20. Koontongkaew S. The tumor microenvironment contribution to development, growth, invasion and metastasis of head and neck squamous cell carcinomas. J Cancer 2013;4:66-83.
- 21. Curry JM, Sprandio J, Cognetti D, et al. Tumor microenvironment in head and neck squamous cell carcinoma. Semin Oncol 2014;41:217-34.
- 22. Damar M, Dinç AE, Erdem D, et al. Pretreatment Neutrophil-Lymphocyte Ratio in Salivary Gland Tumors Is Associated with Malignancy. Otolaryngol Head Neck Surg 2016;155:988-96.
- 23. Kum RO, Ozcan M, Baklaci D, et al. Elevated neutrophil-to-lymphocyte ratio in squamous cell carcinoma of larynx compared to benign and precancerous laryngeal lesions. Asian Pac J Cancer Prev 2014;15:7351-5.
- 24. Hussain SP, Harris CC. Inflammation and cancer: an ancient link with novel potentials. Int J Cancer 2007;121:2373-80.
- 25. Jaiswal M, LaRusso NF, Burgart LJ, Gores GJ. Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism. Cancer Res 2000;60:184-90.
- 26. Waldner M, Schimanski CC, Neurath MF. Colon cancer and the immune system: the role of tumor invading T cells. World J Gastroenterol 2006;12:7233-8.
- 27. Rachidi S, Wallace K, Wrangle JM, Day TA, Alberg AJ, Li Z. Neutrophil-to-lymphocyte ratio and overall survival in all sites of head and neck squamous cell carcinoma. Head Neck 2016;38:1068-74.
- 28. Ozturk K, Akyildiz NS, Uslu M, Gode S, Uluoz U. The effect of preoperative neutrophil, platelet and lymphocyte counts on local recurrence and survival in early-stage tongue cancer. Eur Arch Otorhinolaryngol 2016;273:4425-9.
- 29. Deveci İ, Sürmeli M. Correlation of Systemic Immune-Inflammation Index and Neutrophil-to-Lymphocyte Ratio with Histopathological Findings in Patients with Tongue Cancer. Haydarpasa Numune Med J 2018;58:122-7.
- 30. Chen S, Guo J, Feng C, Ke Z, Chen L, Pan Y. The preoperative platelet-lymphocyte ratio versus neutrophil-lymphocyte ratio: which is better as a prognostic factor in oral squamous cell carcinoma? Ther Adv Med Oncol 2016;8:160-7.
- 31. Ma H, Lin Y, Wang L, et al. Primary lymphoepithelioma-like carcinoma of salivary gland: sixty-nine cases with long-term follow-up. Head Neck 2014;36:1305-12.
- 32. Aziz MH, Sideras K, Aziz NA, et al. The Systemic-immune-inflammation Index Independently Predicts Survival and Recurrence in Resectable Pancreatic Cancer and its Prognostic Value Depends on Bilirubin Levels: a Retrospective Multicenter Cohort Study. Ann Surg 2019;270:139-46.
- 33. Dolan RD, Lim J, McSorley ST, Horgan PG, McMillan DC. The role of the systemic inflammatory response in predicting outcomes in patients
APA | erdiş e, Yücel B (2020). Prognostic Significance of Inflammatory Markers in Patients with Oral Cavity Cancers. , 271 - 277. 10.32448/entupdates.696940 |
Chicago | erdiş eda,Yücel Birsen Prognostic Significance of Inflammatory Markers in Patients with Oral Cavity Cancers. (2020): 271 - 277. 10.32448/entupdates.696940 |
MLA | erdiş eda,Yücel Birsen Prognostic Significance of Inflammatory Markers in Patients with Oral Cavity Cancers. , 2020, ss.271 - 277. 10.32448/entupdates.696940 |
AMA | erdiş e,Yücel B Prognostic Significance of Inflammatory Markers in Patients with Oral Cavity Cancers. . 2020; 271 - 277. 10.32448/entupdates.696940 |
Vancouver | erdiş e,Yücel B Prognostic Significance of Inflammatory Markers in Patients with Oral Cavity Cancers. . 2020; 271 - 277. 10.32448/entupdates.696940 |
IEEE | erdiş e,Yücel B "Prognostic Significance of Inflammatory Markers in Patients with Oral Cavity Cancers." , ss.271 - 277, 2020. 10.32448/entupdates.696940 |
ISNAD | erdiş, eda - Yücel, Birsen. "Prognostic Significance of Inflammatory Markers in Patients with Oral Cavity Cancers". (2020), 271-277. https://doi.org/10.32448/entupdates.696940 |
APA | erdiş e, Yücel B (2020). Prognostic Significance of Inflammatory Markers in Patients with Oral Cavity Cancers. ENT Updates, 10(1), 271 - 277. 10.32448/entupdates.696940 |
Chicago | erdiş eda,Yücel Birsen Prognostic Significance of Inflammatory Markers in Patients with Oral Cavity Cancers. ENT Updates 10, no.1 (2020): 271 - 277. 10.32448/entupdates.696940 |
MLA | erdiş eda,Yücel Birsen Prognostic Significance of Inflammatory Markers in Patients with Oral Cavity Cancers. ENT Updates, vol.10, no.1, 2020, ss.271 - 277. 10.32448/entupdates.696940 |
AMA | erdiş e,Yücel B Prognostic Significance of Inflammatory Markers in Patients with Oral Cavity Cancers. ENT Updates. 2020; 10(1): 271 - 277. 10.32448/entupdates.696940 |
Vancouver | erdiş e,Yücel B Prognostic Significance of Inflammatory Markers in Patients with Oral Cavity Cancers. ENT Updates. 2020; 10(1): 271 - 277. 10.32448/entupdates.696940 |
IEEE | erdiş e,Yücel B "Prognostic Significance of Inflammatory Markers in Patients with Oral Cavity Cancers." ENT Updates, 10, ss.271 - 277, 2020. 10.32448/entupdates.696940 |
ISNAD | erdiş, eda - Yücel, Birsen. "Prognostic Significance of Inflammatory Markers in Patients with Oral Cavity Cancers". ENT Updates 10/1 (2020), 271-277. https://doi.org/10.32448/entupdates.696940 |